Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price hits fresh 52-week high after Rs 785.40 trade

Akums Drugs & Pharmaceuticals Share Price moved to Rs 785.40 on 01 September 2026, up Rs 8.60 or 1.11% from the previous close of Rs 776.80, after the stock touched a fresh 52-week high of Rs 788.95. The company’s market capitalisation stood at Rs 12,158.69 crore, placing the move in a clearly quantifiable market context. The latest AKUMS Share Price action is therefore a fresh 52-week high event, not an all-time high claim.

The day’s range was tight around the upper end of the session, with an open of Rs 777.55 and a low of Rs 776.45 before the price reached the day high and yearly high of Rs 788.95. Turnover was Rs 0.23 crore. The supplied data confirms the price event and the session range, but it does not establish a company-specific catalyst. For readers tracking Akums Drugs & Pharmaceuticals Share Price Today, Univest is presenting the event as a factual market update with valuation and sector context.

In stock news terms, AKUMS Share Price Today is drawing attention because the move coincided with a fresh one-year high, a market cap above Rs 12,000 crore and a valuation profile that can be benchmarked against the pharmaceuticals and drugs universe. Univest notes the event-driven nature of the move without attributing it to an unverified trigger.

Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 785.4
Previous Close	Rs 776.8
Today's Move	+Rs 8.6 (+1.11%)
Open	Rs 777.55
High	Rs 788.95
Low	Rs 776.45
Turnover	Rs 0.23 crore
Market Capitalisation	Rs 12,158.69 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 785.4 versus the previous close of Rs 776.8, a rise of 1.11%. The stock opened at Rs 777.55, reached a high of Rs 788.95 and touched a low of Rs 776.45.

Akums Drugs & Pharmaceuticals Share Price Today showed a clear upward session structure relative to the previous close, with Rs 785.40 compared with Rs 776.80 yesterday. The absolute gain was Rs 8.60 and the percentage change was 1.11%. The stock opened at Rs 777.55, remained near the lower end of the day initially at Rs 776.45, and then reached Rs 788.95, which was also the fresh 52-week high and the day high.

That placement matters because the stock closed the day’s trading window only slightly below the peak, leaving the AKUMS Share Price within touching distance of the session high. The breakout distance from the previous 52-week high, using the supplied figures, is 0.00% because the new high equals Rs 788.95. For readers using Akums Drugs & Pharmaceuticals Share Price Live data, the verified takeaway is simple: the stock set a new yearly high and held most of the day’s gain into the latest price print.

Turnover of Rs 0.23 crore is a factual traded-value measure for the session. It does not by itself explain why the move happened, but it does show the value of business done at the quoted prices. In AKUMS Stock News, that combination of a fresh 52-week high and a positive daily move is the core event, while the reason remains unconfirmed in the supplied data. The next section shifts from price action to the company’s financial backdrop.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,158.69 crore
P/E Ratio	41.91x
P/B Ratio	3.58x
ROE	8.06%
ROCE	14.77%
EPS	Rs 18.53
Book Value Per Share	Rs 216.98
Dividend Yield	0.39%

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 41.91x, P/B 3.58x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12158.69 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.91x, P/B at 3.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.39%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.86x, median ROE of 11.82%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.91x
Benchmark Median P/E	30.86x
Benchmark Average P/E	48.06x
Benchmark P/E Range	3.87x to 667.16x
Company P/B Ratio	3.58x
Benchmark Median P/B	2.88x
Company ROE	8.06%
Benchmark Median ROE	11.82%
Company ROCE	14.77%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 12,158.69 crore
Benchmark Median Market Cap	Rs 679.12 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.91x, which is above the benchmark median of 30.86x, a difference of +35.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.82%, a difference of -31.81%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.63%, a difference of +8.36%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sequent Scientific Ltd.	VIYASH	11,756.53	67.79	4.13	9.06	13.1
CORONA Remedies Ltd.	CORONA	12,739.95	62.93	15.52	27.36	31.74
Sudeep Pharma Ltd.	SUDEEPPHRM	13,020.15	74.85	14.8	25.37	28.5
Blue Jet Healthcare Ltd.	BLUEJET	10,912.69	46.53	4.88	19.88	27.18
Jubilant Pharmova Ltd.	JUBLPHARMA	14,049.39	39.92	1.97	5.97	8.69

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.91x compared with the displayed peer median of 62.93x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,158.69 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Akums Drugs & Pharmaceuticals

• Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high at Rs 788.95.
• The latest AKUMS Share Price print was Rs 785.40, up Rs 8.60 or 1.11% from the previous close.
• Market capitalisation stood at Rs 12,158.69 crore for Akums Drugs & Pharmaceuticals Share Price Today.
• P/E is 41.91, P/B is 3.58, ROE is 8.06 and ROCE is 14.77 in the supplied fundamentals.
• Against the same-industry benchmark, AKUMS Share Price is above the median P/E and P/B, while ROCE is above the median and ROE is below it.

About Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE as AKUMS, and the supplied profile places it in a same-industry benchmark set used for valuation and return comparisons. For readers following Akums Drugs & Pharmaceuticals Share Price, this company context is useful because it connects the 52-week high event with the broader listed pharmaceutical universe.

The supplied financial series also shows revenue and profit figures across multiple quarters, which gives Akums Drugs & Pharmaceuticals Share Price Today a measurable operating backdrop. Univest includes this company overview so that AKUMS Stock News can be read alongside the company’s reported market cap, earnings-related metrics and benchmark data rather than as a stand-alone price update.

Track Akums Drugs & Pharmaceuticals Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, market capitalisation, valuation ratios, financial results, shareholding pattern, 52-week levels and related market insights. Univest also places AKUMS Share Price Today in the context of sector benchmarks and peer comparison, so the stock can be followed with structured, fact-based updates.

For users searching Akums Drugs & Pharmaceuticals Share Price Live, Univest keeps the stock page aligned with the latest price event, the one-year high, company financials and the listed peer universe. That makes AKUMS Stock Analysis easier to read in one place.

Frequently Asked Questions

Why did Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high?

Ans. The supplied data confirms that Akums Drugs & Pharmaceuticals Share Price touched Rs 788.95, a fresh 52-week high. It does not establish a company-specific catalyst, so the event should be read as a verified price update.

What is Akums Drugs & Pharmaceuticals Share Price Today?

Ans. Akums Drugs & Pharmaceuticals Share Price Today was Rs 785.40, up Rs 8.60 or 1.11% from the previous close of Rs 776.80. The stock also set a fresh yearly high at Rs 788.95.

What was the 52-week high for AKUMS?

Ans. The fresh 52-week high for AKUMS was Rs 788.95. The session high matched that level, so the stock reached a new one-year peak during the trading day. The stock moved 1.11% during the session.

What is the market capitalisation of Akums Drugs & Pharmaceuticals?

Ans. Akums Drugs & Pharmaceuticals Share Price was associated with a market capitalisation of Rs 12,158.69 crore in the supplied data. That places the company in a different scale from the industry median shown in the benchmark set.

How does Akums compare with the industry benchmark on valuation?

Ans. Akums Drugs & Pharmaceuticals has a P/E of 41.91 and a P/B of 3.58. Both are above the same-industry medians of 30.86 and 2.88, respectively, in the supplied Healthcare benchmark.

How do ROE and ROCE look for Akums?

Ans. Akums reports ROE of 8.06 and ROCE of 14.77. ROE is below the industry median of 11.82, while ROCE is above the median of 13.63 in the same-industry benchmark. ROE stands at 8.06%.

What do EPS and book value show for Akums Drugs & Pharmaceuticals?

Ans. EPS is Rs 18.53 and book value per share is Rs 216.98. EPS reflects earnings attributable to each share, while book value shows accounting net worth behind each share at the reported date.

What is the dividend yield for AKUMS?

Ans. The supplied dividend yield for AKUMS is 0.39. It is a historical or current payout measure relative to the share price and should be read alongside valuation and earnings data.

How does AKUMS compare with listed peers?

Ans. AKUMS has a market cap of Rs 12,158.69 crore and a P/E of 41.91. That is below some peers such as Sequent Scientific and CORONA Remedies, while remaining above Jubilant Pharmova on P/E.

Where can I track Akums Drugs & Pharmaceuticals Share Price?

Ans. You can track Akums Drugs & Pharmaceuticals Share Price on Univest, where live price updates, valuation ratios, financial results, shareholding pattern and 52-week levels are presented together for easier stock monitoring.